Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of p38MAPK cascade. [GOC:TermGenie]
The p38 mitogen-activated protein kinase (MAPK) cascade is a highly conserved signaling pathway that plays crucial roles in cellular responses to various stimuli, including stress, inflammation, and growth factors. Its regulation is tightly controlled at multiple levels, ensuring precise and appropriate activation and termination.
The p38 MAPK cascade is composed of a series of protein kinases that act sequentially to relay signals from upstream activators to downstream targets. The core components of the cascade include:
1. **Upstream activators:** These include a variety of stimuli that activate the pathway, such as:
- **Stress-activated protein kinases (SAPKs):** These kinases, like MKK3 and MKK6, are activated by environmental stresses, such as oxidative stress, heat shock, and UV radiation.
- **Tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2):** This protein is activated by TNF and other cytokines, leading to the activation of the p38 MAPK cascade.
- **Toll-like receptors (TLRs):** These receptors recognize pathogen-associated molecular patterns (PAMPs) and activate the p38 MAPK cascade, leading to immune responses.
2. **MAP2K/MKK:** These kinases are activated by upstream activators and phosphorylate and activate the p38 MAPK. The main MKKs involved in p38 MAPK activation are MKK3 and MKK6.
3. **p38 MAPK:** This kinase is activated by MKK3 and MKK6 and phosphorylates downstream targets, leading to a variety of cellular responses. There are four main isoforms of p38 MAPK: p38α, p38β, p38γ, and p38δ.
4. **Downstream targets:** These include transcription factors, kinases, and other signaling proteins that mediate the cellular responses to p38 MAPK activation. Some important downstream targets include:
- **ATF2:** This transcription factor is involved in the regulation of stress-responsive genes.
- **MK2:** This kinase plays a role in the regulation of cytokine production and inflammation.
- **MAPKAP2:** This kinase is involved in the regulation of cytoskeletal organization and cell migration.
**Regulation of the p38 MAPK cascade:**
The p38 MAPK cascade is tightly regulated at multiple levels to ensure appropriate and precise activation and deactivation:
**1. Upstream activation:**
* The activation of upstream activators is regulated by various mechanisms, including ligand binding, receptor dimerization, and protein-protein interactions.
* The activity of upstream activators is further controlled by feedback mechanisms, such as phosphorylation and ubiquitination.
**2. MKK activation:**
* MKKs are activated by upstream activators through phosphorylation.
* The activity of MKKs is also regulated by feedback mechanisms, such as phosphorylation and dephosphorylation.
**3. p38 MAPK activation:**
* p38 MAPK is activated by MKK3 and MKK6 through phosphorylation.
* The activation of p38 MAPK is also regulated by feedback mechanisms, such as phosphorylation and dephosphorylation.
**4. Downstream signaling:**
* The activity of downstream targets is regulated by various mechanisms, including phosphorylation, dephosphorylation, and protein-protein interactions.
**5. Deactivation:**
* The p38 MAPK cascade is deactivated by phosphatases, which remove phosphate groups from activated kinases.
* Other mechanisms, such as ubiquitination and degradation, also contribute to the inactivation of the cascade.
**Consequences of p38 MAPK pathway dysregulation:**
Dysregulation of the p38 MAPK cascade can contribute to a variety of diseases, including:
* **Inflammation:** Overactivation of the p38 MAPK cascade can contribute to chronic inflammation and autoimmune diseases.
* **Cancer:** Both overactivation and inhibition of the p38 MAPK cascade can promote cancer cell growth and metastasis.
* **Neurodegenerative diseases:** Dysregulation of the p38 MAPK cascade is implicated in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.
* **Cardiovascular diseases:** Aberrant p38 MAPK signaling can contribute to cardiovascular disease, such as atherosclerosis and heart failure.
In summary, the p38 MAPK cascade is a complex and highly regulated signaling pathway that plays a crucial role in various cellular responses. Its regulation is tightly controlled at multiple levels to ensure precise and appropriate activation and termination. Dysregulation of the p38 MAPK cascade can have significant consequences for human health, contributing to a variety of diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Disabled homolog 2-interacting protein | A disabled homolog 2-interacting protein that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q5VWQ8] | Homo sapiens (human) |
Advanced glycosylation end product-specific receptor | An advanced glycosylation end product-specific receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15109] | Homo sapiens (human) |
Galectin-9 | A galectin-9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O00182] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
quinolinic acid | pyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups. quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan. Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS. | pyridinedicarboxylic acid | Escherichia coli metabolite; human metabolite; mouse metabolite; NMDA receptor agonist |
lactose | beta-lactose : The beta-anomer of lactose. lactose : A glycosylglucose disaccharide, found most notably in milk, that consists of D-galactose and D-glucose fragments bonded through a beta-1->4 glycosidic linkage. The glucose fragment can be in either the alpha- or beta-pyranose form, whereas the galactose fragment can only have the beta-pyranose form. Lactose: A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry. | lactose | |
methyl alpha-d-galactopyranoside | methyl alpha-D-galactoside : An alpha-D-galactoside having a methyl substituent at the anomeric position. methyl-galactopyranoside: structure in first source | alpha-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
matrine | alkaloid | ||
methyl beta-galactoside | methyl beta-D-galactoside : A beta-D-galactopyranoside having a methyl substituent at the anomeric position. methyl beta-galactoside: RN given refers to (beta-D)-isomer methyl galactoside : A methyl glycoside in which the H of the OH group on C-1 of galactose is replaced by a methyl group. | beta-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
thiodigalactoside | thiodigalactoside: RN given refers to beta-D-galactopyranoside (D-Gal)-isomer | ||
methyl lactoside | beta-D-Gal-(1->4)-beta-D-Glc-OMe : A methyl glycoside comprising methyl beta-D-glucoside having an beta-D-galactosyl residue at the 4-position. | disaccharide derivative; methyl glycoside | |
2-hydroxyestradiol | 2-hydroxy-17beta-estradiol : A 2-hydroxy steroid that consists of 17beta-estradiol having an additional hydroxy group at position 2. 2-hydroxyestradiol: catechol estrogen; RN given refers to (17 beta)-isomer | 17beta-hydroxy steroid; 2-hydroxy steroid | carcinogenic agent; human metabolite; metabolite; mouse metabolite; prodrug |
n-acetyllactosamine | N-acetyllactosamine : A beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre. N-acetyllactosamine: RN given refers to D-isomer | beta-D-Galp-(1->4)-D-GlcpNAc | |
galactal | galactal: RN given refers to cpd with unspecified isomeric designation; structure | anhydrohexose; glycal | |
vilazodone | vilazodone : A 1-benzofuran that is 5-(piperazin-1-yl}-1-benzofuran-2-carboxamide having a (5-cyanoindol-3-yl)butyl group attached at position N-4 on the piperazine ring. Used for the treatment of major depressive disorder. | 1-benzofurans; indoles; monocarboxylic acid amide; N-alkylpiperazine; N-arylpiperazine; nitrile | antidepressant; serotonergic agonist; serotonin uptake inhibitor |
fps-zm1 | FPS-ZM1: a neuroprotective agent and RAGE receptor antagonist; structure in first source | ||
n(delta)-(5-methyl-4-oxo-2-imidazolin-2-yl)ornithine | N(delta)-(5-methyl-4-oxo-2-imidazolin-2-yl)ornithine: RN given for (L)-isomer; structure in first source |